BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Press Releases

  Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

  August 31, 2026

   · 

  1 min read
• Press Releases

  Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

  August 31, 2026

   · 

  8 min read
• Press Releases

  BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

  August 31, 2026

   · 

  7 min read
• Press Releases

  AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

  August 31, 2026

   · 

  1 min read
• Press Releases

  Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

  August 31, 2026

   · 

  5 min read
• Press Releases

  ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

  August 31, 2026

   · 

  8 min read
• Press Releases

  Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

  August 31, 2026

   · 

  9 min read
• Press Releases

  Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

  August 31, 2026

   · 

  9 min read
• Press Releases

  TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis

  August 31, 2026

   · 

  6 min read
• Press Releases

  T-MAXIMUM B7-H3-Targeted Allogeneic CAR-T Therapy MT027 Receives FDA Fast Track Designation, Accelerating Global Development for Intracranial Solid Tumors

  August 31, 2026

   · 

  4 min read